Edition:
United States

Pharmos Corp (PARS.PK)

PARS.PK on OTC Markets Group

0.01USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,669
52-wk High
$0.04
52-wk Low
$0.00

Chart for

About

Pharmos Corporation (Pharmos) is a biopharmaceutical company that discovers and develops therapeutics to treat a range of metabolic and nervous system disorders, including gout, disorders of the brain-gut axis, pain/inflammation and autoimmune disorders. Pharmos owns the rights to both R and S Tofisopam. These are the two... (more)
No analyst recommendations are available for .

Overall

Beta: 0.31
Market Cap(Mil.): $0.61
Shares Outstanding(Mil.): 60.17
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

Earnings vs. Estimates

No consensus analysis data available.